{"id":611973,"date":"2026-09-04T18:36:32","date_gmt":"2026-09-04T18:36:32","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/611973\/contact-lens-import-compliance-in-2026-a-10country-compliance-map-from-constar.html"},"modified":"2026-09-04T18:36:32","modified_gmt":"2026-09-04T18:36:32","slug":"contact-lens-import-compliance-in-2026-a-10country-compliance-map-from-constar","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/611973\/contact-lens-import-compliance-in-2026-a-10country-compliance-map-from-constar.html","title":{"rendered":"Contact Lens Import Compliance in 2026: A 10-Country Compliance Map from Constar"},"content":{"rendered":"<p style=\"text-align: justify\"><strong>BAIYIN, GANSU, CHINA &#8211; September 4, 2026 &#8211;<\/strong> Few products travel with more paperwork than contact lenses. Classified as medical devices in almost every regulated market, lenses must clear registration, certification, and import hurdles that <strong>differ from one country to the next<\/strong> &mdash; no two markets file the same documentation or accept the same approvals. A CE mark does not satisfy the US FDA, an FDA 510(k) does not unlock China, and India will run its own assessment even when a product is already approved in Europe and America. For distributors, this article was compiled as a 2026 field guide by <a rel=\"nofollow noopener\" href=\"https:\/\/www.constarfactory.com\/\" target=\"_blank\">Constar (Gansu Constar Technology Group)<\/a>, a China-based contact lens OEM and ODM manufacturer exporting to more than 40 countries, and maps the contact lens import compliance picture across ten major markets &mdash; covering regulator, route to market, local representative requirements, and what buyers must verify before shipping a container.<\/p>\n<p style=\"text-align: justify\">This 10-country map is organized into quick-reference entries so distributors and brand owners can compare requirements at a glance and prioritize the certification work that unlocks their target markets.<\/p>\n<p style=\"text-align: justify\">Contact Lens Import Compliance at a Glance<\/p>\n<ul style=\"text-align: justify\">\n<li><strong>Local representative is mandatory in most markets<\/strong> &mdash; EU, UK, China, Japan, Australia, Canada, India and South Korea all require a local agent, sponsor, MAH or Responsible Person.<\/li>\n<li><strong>One approval never covers another market.<\/strong> CE, FDA, TGA and CDSCO each run independent assessments.<\/li>\n<li><strong>Certification breadth is the real competitive advantage<\/strong> &mdash; fewer than a handful of global factories hold FDA, CE 0197 and ISO 13485 simultaneously.<\/li>\n<li><strong>Prescription rules vary by market but lean to mandatory<\/strong> &mdash; most regulated economies require a valid prescription for all lenses, cosmetic lenses included.<\/li>\n<\/ul>\n<p style=\"text-align: justify\">1. United States &mdash; FDA (Class II \/ 510(k))<\/p>\n<p style=\"text-align: justify\">Lenses fall under 21 CFR Part 886 and require establishment registration, device listing and premarket clearance via the <strong>510(k)<\/strong> pathway &mdash; or full <strong>PMA<\/strong> for higher-risk products. Foreign manufacturers must appoint a <strong>US Agent<\/strong>, and a valid prescription is required for all lenses under the <a rel=\"nofollow noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/consumer-products\/contact-lenses\" target=\"_blank\">FDA Contact Lenses program<\/a> and the FTC Contact Lens Rule. Clinical data is typically needed in only about 10% of 510(k) submissions, which keeps the US pathway comparatively fast for conventional lenses.<\/p>\n<p style=\"text-align: justify\">2. European Union &mdash; CE Marking under MDR 2017\/745<\/p>\n<p style=\"text-align: justify\">Since May 2021, lenses need a <strong>CE mark<\/strong> assessed by an independent notified body under Medical Device Regulation (EU) 2017\/745 &mdash; see the official regulation text at <a rel=\"nofollow noopener\" href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2017\/745\/oj\/eng\" target=\"_blank\">EUR-Lex<\/a>. Lenses are typically <strong>Class IIa\/IIb<\/strong>; the optical-device notified body designation <strong>CE 0197<\/strong> is held by only a small number of organizations worldwide. Non-EU manufacturers must appoint an <strong>EU Authorized Representative<\/strong>, maintain technical documentation for 10 years, and comply with UDI requirements (mandatory since 2021) and post-market surveillance under Article 61.<\/p>\n<p style=\"text-align: justify\">3. United Kingdom &mdash; MHRA \/ UKCA<\/p>\n<p style=\"text-align: justify\">Post-Brexit, lenses entering Great Britain require <strong>UKCA marking<\/strong> (with CE transition still in effect for many products) and <strong>MHRA registration<\/strong> before market placement. A <strong>UK Responsible Person<\/strong> is mandatory for manufacturers based outside the UK, and prescriptions are enforced by optometrists under existing practice frameworks.<\/p>\n<p style=\"text-align: justify\">4. China &mdash; NMPA (Class III)<\/p>\n<p style=\"text-align: justify\">China treats contact lenses as <strong>Class III devices<\/strong>, its highest-risk category, regardless of the class assigned in the country of origin. Requirements include NMPA registration, <strong>in-country type testing<\/strong> (only biocompatibility per ISO 10993 \/ GB 16886 is accepted from abroad), a mandatory <strong>local agent<\/strong>, and proof of home-market approval. Full registration is typically a multi-year, six-figure exercise.<\/p>\n<p style=\"text-align: justify\">5. Japan &mdash; PMDA \/ MHLW<\/p>\n<p style=\"text-align: justify\">Under Japan&#8217;s <strong>PMD Act<\/strong>, lenses are classified at Class II or III and require marketing authorization through the Pharmaceuticals and Medical Devices Agency (PMDA). Foreign manufacturers must appoint a Japan-based <strong>Marketing Authorization Holder (MAH)<\/strong>, hold Japanese QMS (J-QMS) audits, and work through a registered certification body for Class II devices.<\/p>\n<p style=\"text-align: justify\">6. Australia &mdash; TGA (ARTG)<\/p>\n<p style=\"text-align: justify\">Lenses are <strong>Class IIa\/IIb<\/strong> devices requiring <strong>ARTG inclusion<\/strong> before sale, with a mandatory <strong>Australian local sponsor<\/strong> that holds legal responsibility. Advertising of contact lenses to the public is restricted, so marketing must run through the practitioner channel.<\/p>\n<p style=\"text-align: justify\">7. Canada &mdash; Health Canada<\/p>\n<p style=\"text-align: justify\">Health Canada regulates lenses as <strong>Class II\/III<\/strong> devices requiring a <strong>Medical Device License<\/strong> (Class III), plus an <strong>Establishment License<\/strong> for importers and distributors. An <strong>ISO 13485<\/strong> quality system is effectively required to demonstrate compliance.<\/p>\n<p style=\"text-align: justify\">8. Saudi Arabia &mdash; SFDA<\/p>\n<p style=\"text-align: justify\">The Saudi Food and Drug Authority (<strong>SFDA<\/strong>) requires product registration before lenses can be imported across GCC markets, with <strong>Arabic-language labeling and documentation<\/strong> mandatory for customs clearance. Lenses are increasingly treated under full medical-device registration rules as the region&#8217;s beauty optics demand grows.<\/p>\n<p style=\"text-align: justify\">9. India &mdash; CDSCO (MDR 2017)<\/p>\n<p style=\"text-align: justify\">India&#8217;s regulatory net closed around all medical devices in 2026. Importing agencies must hold a <strong>CDSCO import license (Forms MD-14 \/ MD-15)<\/strong> via the SUGAM portal, and <strong>contact lenses now require mandatory BIS certification under IS 15923<\/strong>. Foreign manufacturers must appoint an <strong>Indian Authorized Agent (IAA)<\/strong>, supply a Free Sale Certificate from the country of origin (not older than 2 years), and demonstrate ISO 13485. Registration typically takes 6&ndash;12 months.<\/p>\n<p style=\"text-align: justify\">10. South Korea &mdash; MFDS<\/p>\n<p style=\"text-align: justify\">Lenses are <strong>Class II\/III<\/strong> under the Ministry of Food and Drug Safety (<strong>MFDS<\/strong>), requiring preliminary <strong>KFDA\/MFDS approval<\/strong> before import. A <strong>licensed local importer<\/strong> is mandatory, Korean-language labeling is required, and documentation must be submitted in Korean.<\/p>\n<p style=\"text-align: justify\">Southeast Asia: A Patchwork Within a Region<\/p>\n<p style=\"text-align: justify\">Southeast Asia is the least uniform region. Indonesia requires <strong>AKL approval<\/strong>; Vietnam uses a tiered system assigning lenses to <strong>Class B<\/strong> with a different dossier than Class A; Thailand&#8217;s TFDA requires product registration plus a local representative; Malaysia enforces its own <strong>Medical Device Authority<\/strong> standards. Suppliers with region-specific certifications &mdash; like the <a rel=\"nofollow noopener\" href=\"https:\/\/www.constarfactory.com\/markets-we-serve\/\" target=\"_blank\">multi-market compliance portfolio Constar maintains across 40+ countries<\/a>, spanning FDA, CE 0197, TGA, SFDA, AKL and Vietnam Class B &mdash; remove the need to source from different factories for different geographies.<\/p>\n<p style=\"text-align: justify\">What Distributors Should Verify Before Placing an Order<\/p>\n<ol style=\"text-align: justify\">\n<li><strong>Market-specific certifications, not one general credential.<\/strong> A CE mark alone does not satisfy an FDA, NMPA or CDSCO, and vice versa.<\/li>\n<li><strong>Batch-level documentation.<\/strong> Request Certificates of Analysis, biocompatibility test reports and material safety data sheets with every shipment.<\/li>\n<li><strong>A proven customs track record.<\/strong> Established manufacturers will have documented processes for import clearance in your target region &mdash; the difference between a clean landing and a seized container.<\/li>\n<\/ol>\n<p style=\"text-align: justify\"><strong>Frequently Asked Questions<\/strong><\/p>\n<p style=\"text-align: justify\">Is a CE mark enough to import contact lenses into any country?<\/p>\n<p style=\"text-align: justify\">No. CE marking only covers the European Economic Area. The US FDA, China&#8217;s NMPA, Japan&#8217;s PMDA, India&#8217;s CDSCO and every other major regulator run independent assessments, and most also require a local representative for the importing manufacturer.<\/p>\n<p style=\"text-align: justify\">Do all countries require contact lens import registration?<\/p>\n<p style=\"text-align: justify\">In any regulated market, yes. Contact lenses are classified as medical devices, so registration or authorization is required before import &mdash; plus, in most markets, a doctor-issued prescription to sell them. Markets without such controls are where counterfeit and unapproved lenses circulate.<\/p>\n<p style=\"text-align: justify\">Why do contact lens compliance requirements change so often?<\/p>\n<p style=\"text-align: justify\">Because medical device rules are continuously tightening &mdash; from the EU MDR 2017\/745 to China&#8217;s NMPA Class III regime to India&#8217;s 2026 mandatory BIS certification (IS 15923). Buyers should re-verify compliance requirements annually before renewing supplier contracts.<\/p>\n<p style=\"text-align: justify\"><strong>About Constar<\/strong><\/p>\n<p style=\"text-align: justify\">Gansu Constar Technology Group Co., Ltd. is a <a rel=\"nofollow noopener\" href=\"https:\/\/www.constarfactory.com\/about\/\" target=\"_blank\">China-based contact lens OEM and ODM manufacturer<\/a> serving brands and distributors in more than 40 countries. Founded more than 40 years ago and headquartered in Baiyin, Gansu Province, the company operates six production facilities with a combined capacity of over <strong>15 million lenses per month<\/strong>, and holds US FDA (510(k), Class II), EU CE 0197 (MDR), ISO 13485, TGA, SFDA, AKL and Class B (Vietnam) certifications.<\/p>\n<p style=\"text-align: justify\"><strong>Sources:&nbsp;<\/strong>FDA &mdash; Contact Lenses (Medical Devices Program)EUR-Lex &mdash; Medical Device Regulation (EU) 2017\/745CDSCO &mdash; Medical Device Rules 2017 (Forms MD-14 \/ MD-15)Constar &mdash; Markets We Serve<\/p>\n<p class=\"caps\"><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/constarfactory.com_190718.html\">Gansu Constar Technology Group CO.,LTD<\/a><br \/><strong>Contact Person:<\/strong> Media Relations<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=contact-lens-import-compliance-in-2026-a-10country-compliance-map-from-constar\">Send Email<\/a><br \/><strong>Country:<\/strong> China<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.constarfactory.com\/\" target=\"_blank\">https:\/\/www.constarfactory.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=contact-lens-import-compliance-in-2026-a-10country-compliance-map-from-constar\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BAIYIN, GANSU, CHINA &#8211; September 4, 2026 &#8211; Few products travel with more paperwork than contact lenses. Classified as medical devices in almost every regulated market, lenses must clear registration,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/611973"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=611973"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/611973\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=611973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=611973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=611973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}